Automated discovery of conjugates drives a reverse-metabolomics strategy: From LC-HRMS-based phase II prediction to GC-HRMS validation of phase I metabolites of 6β-chlorotestosterone
Journal of Chromatography A · 2026
DOI: 10.1016/j.chroma.2026.467296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatography A, 2026. Verfasst von Genye He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, China Agricultural University, Beijing, 100193, China; Beijing Anti-doping Laboratory, Beijing Sport University, 10084, Chin…. Hauptthemen laut MEDLINE: Metabolomics, Testosterone, Gas Chromatography-Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: World Anti-Doping Agency.
Abstract (Originalsprache)
Anti-doping and forensic science detection rely fundamentally on target-based methodologies, especially for metabolite screening and identification. Traditional manual screening is constrained by low efficiency and knowledge bias. Conversely, although current metabolomics and machine-learning approaches efficiently calculate lots of potential biomarkers using statistical methods, these findings necessitate further rigorous screening to isolate true biomarkers that satisfy the requirements of both anti-doping and forensic science. To bridge the gap between machine learning and manual screening, we developed an innovative reverse-metabolomics strategy: utilizing LCHRMS for Phase II conjugate automated prediction as well as GCHRMS for targeted Phase I tentative validation. In the study of 6β‑chloro-testosterone (6β-Cl-T) metabolism, while LCHRMS (via Compound Discoverer software) initially predicted 244 putative phase II metabolites, the integration of GCHRMS, following the release of Phase I metabolites and subsequent derivatization, acted as a high-precision filter to further elucidate these candidates. 74 of the 244 candidates were putatively validated as candidate biomarkers. Eliminating high-throughput false positives, this workflow boosts data confidence in anti-doping and clinical metabolomics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, China Agricultural University, Beijing, 100193, China; Beijing Anti-doping Laboratory, Beijing Sport University, 10084, China. Electronic address: hegenye@163.com.
- Beijing Anti-doping Laboratory, Beijing Sport University, 10084, China. Electronic address: nadl.zhusisi@bsu.edu.cn.
- Beijing Anti-doping Laboratory, Beijing Sport University, 10084, China.
- Department of Chemistry, China Agricultural University, Beijing, 100193, China.
- Department of Chemistry, China Agricultural University, Beijing, 100193, China. Electronic address: jli@cau.edu.cn.
Förderung
- World Anti-Doping Agency
Zitieren
APA
He, G., Zhu, S., Liu, Y., Liu, X., Wang, Z., Zhang, L., Gao, H., & Li, J. (2026). Automated discovery of conjugates drives a reverse-metabolomics strategy: From LC-HRMS-based phase II prediction to GC-HRMS validation of phase I metabolites of 6β-chlorotestosterone. Journal of Chromatography A. https://doi.org/10.1016/j.chroma.2026.467296
Vancouver
He G, Zhu S, Liu Y, Liu X, Wang Z, Zhang L, et al. Automated discovery of conjugates drives a reverse-metabolomics strategy: From LC-HRMS-based phase II prediction to GC-HRMS validation of phase I metabolites of 6β-chlorotestosterone. Journal of Chromatography A. 2026. doi:10.1016/j.chroma.2026.467296
BibTeX
@article{He2026,
author = {He, Genye and Zhu, Sisi and Liu, Yunxi and Liu, Xin and Wang, Zhanliang and Zhang, Lisi and Gao, Haixiang and Li, Jing},
title = {Automated discovery of conjugates drives a reverse-metabolomics strategy: From LC-HRMS-based phase II prediction to GC-HRMS validation of phase I metabolites of 6β-chlorotestosterone},
journal = {Journal of Chromatography A},
year = {2026},
doi = {10.1016/j.chroma.2026.467296}
}
EUVIMED